Skip to main navigation
Skip to search
Skip to main content
UK Health Security Agency Main
Main
Profiles
Research units
Research output
Prizes
Activities
Impacts
Search by expertise, name or affiliation
Rubella
J. E. Banatvala
*
, David Brown
*
Corresponding author for this work
COVID-19 Response
Research output
:
Contribution to journal
›
Article
›
peer-review
316
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rubella'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Rubella
100%
Measles-mumps-rubella Vaccine
60%
Congenital Rubella Syndrome
60%
Developed Countries
40%
Vaccination Program
40%
Uptake Rate
40%
European Countries
20%
Antibody Response
20%
Quantitative PCR
20%
Serum IgE
20%
Measles
20%
Arbovirus
20%
Developmental Anomalies
20%
Enterovirus
20%
Acquired Infections
20%
Developing Countries
20%
Human Herpesvirus 6 (HHV-6)
20%
Salivary Antibodies
20%
Rash
20%
Molecular Epidemiology
20%
Specific IgM
20%
Deafness
20%
Oral Fluid
20%
Parvovirus B19
20%
Blindness
20%
Medicine and Dentistry
Rubella
100%
Congenital Rubella Syndrome
42%
Infection
28%
Uptake Rates
28%
Antibody Response
14%
Arbovirus
14%
Hearing Impairment
14%
Measles Mumps Rubella Vaccine
14%
Immunoglobulin M
14%
Exanthem
14%
Parvovirus B19
14%
Measles
14%
Enterovirus
14%
Human Herpesvirus 6
14%
Reverse Transcription Polymerase Chain Reaction
14%
Immunology and Microbiology
Rubella
100%
Antibody Response
10%
Enterovirus
10%
Human Parvovirus B19
10%
Measles
10%
Arbovirus
10%
MMR Vaccine
10%
Immunoglobulin M
10%
Human Herpesvirus 6
10%
Reverse Transcription Polymerase Chain Reaction
10%